Outsourcing

The Future of Outsourcing

The increasing complexity in drug development and the highly competitive industry landscape are creating a dramatic shift in how pharmaceutical and biotech companies plan for and execute drug development and production.

Why CDMOs Should Consider Value-Based Pricing

Outsourcing product development and manufacturing has become for many pharmaceutical and biotech companies a strategic activity and an integral part of their business model.

The Pharma CDMO Challenge

Logistics performance is a driver of corporate performance!

MENA Pharmaceutical Market

M&A in Pharma and CRO/CMO Industry

Opposites Attract

Pharma: Adapting to an Ever-Changing Environment

East or West? East and West!

Both Positive and Negative Effects

Ensuring Better Efficiency and Consistency

Earning a Large Chunk of the Cake

Pharma R&D Productivity Needs Improvement

Confidentiality is a Potential Pitfall

Consolidation is here to Stay

Changes in Portfolios and Pipelines are Likely

Setting High Standards

A Partner to Relieve the Strain

M&A in Pharma and CRO/CMO Industry

The Expanding Role of Contract Manufacturing

It All Starts with Chemistry

Bridging the Innovation Gap

Logistics Outsourcing has become Common

About 10 years ago, CHEManager decided to present discussions about logistics as a separate theme. Since then, the terms “chemical logistics” and “pharmaceutical logistics” have become established in business and science and with trade associations.

Staying Ahead In Outsourcing

The New Globalism

Harvesting the Sun

A good film needs excitement, drama, heroes and a happy ending. The construction of the world’s largest thermal solar power plant in Morocco has all of these.

Heavy Reliance on Contract Manufacturing

Where Cleanliness Becomes a Challenge

Camelot’s Pharma Management Radar

Syngenta to Cut 1,800 Jobs to Improve Cost Base

‘Transportation Is a Critical Bottleneck’

Accelerating the Benefits Achievable from Biocatalysis

PCRAMS is a Booming Business

United in Philosophy and Approach

Interview with Angelos Orfanos, DHL: Life Science Demands Advanced Infrastructure